who to blame? The management has told the market of the “high level of interests” from sophisticated investors or global pharmaceuticals how many times in the last few years? Nothing has eventuated. Big disappointment to say the least
- Forums
- ASX - By Stock
- NEU
- Ann: Temporary enrolment pause ended in Phase 3 trial in the US
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.78%
!
$12.95

Ann: Temporary enrolment pause ended in Phase 3 trial in the US, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.95 |
Change
0.100(0.78%) |
Mkt cap ! $1.626B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.85 | $6.811M | 520.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 461 | $12.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.97 | 224 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 593 | 12.890 |
6 | 757 | 12.880 |
13 | 3086 | 12.870 |
10 | 3167 | 12.860 |
6 | 3395 | 12.850 |
Price($) | Vol. | No. |
---|---|---|
12.910 | 666 | 7 |
12.920 | 926 | 6 |
12.930 | 1087 | 7 |
12.940 | 2397 | 13 |
12.950 | 1541 | 4 |
Last trade - 15.43pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online